Quanticate partners with KPS Life to build a unique service offering
A new partnership has been formed this month between Quanticate, the global biometric clinical research organisation, and KPS Life, a global functional service provider offering clinical outsourcing solutions to biopharmaceutical and medical device and diagnostic companies.
The combined expertise of the organisations opens up a broader range of services, that complement each other well, meaning that biotech and pharma companies will have access to biometric data services along with global resourcing solutions.
The companies will also be able to utilise their collective experience to offer end-to-end solutions for pharma companies. This will provide a boost in biopharma companies’ capabilities to run clinical research projects.
“We are thrilled to be partnering with KPS Life and offering biotech and pharma companies access to our expert biometric data services alongside KPS Life’s FSP solutions,” commented David Underwood, CEO at Quanticate.
“By combining our expertise, we will be able to provide an end-to-end solution that delivers high-quality data and comprehensive clinical services to sponsors. This partnership represents a significant milestone for Quanticate and KPS Life, and we look forward to working together to deliver exceptional results for our clients.”
The partnership comes as a strategic move, to provide a unique, well balanced service for biopharma companies, opening up a lot of doors for these companies so they can take advantage of their respective expertise.
“Our clients have come to expect high-quality resource solutions and our deep commitment to solving their staffing challenges in this tough labour environment. We are confident that partnering with Quanticate will be a strong addition to our collective service offerings,” stated David Kelly, CEO at KPS Life.
“This partnership represents an exciting opportunity for Sponsor companies to access a full range of services from two expert organisations. We believe our collaboration will help companies achieve their clinical research goals more efficiently and effectively.”
Related News
-
.png)
News On Track at Pharmapack 2024 - The Track Sponsor interview: BD Pharmaceuticals
January 2024 brings both a new year and Europe’s leading packaging and drug delivery event. Bringing the world’s experts in pharmaceutical packaging together in Paris, France, Pharmapack 2024 brings exciting opportunities to learn and colla... -
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News Roche breaks into the obesity drug market with the acquisition of Carmot Therapeutics
In a bid to diversify their therapeutic offerings, Roche takes over Carmot Therapeutics in $2.7 billion deal, with one obesity drug spearheading the venture into the field as they prep for a Phase II in-human trial. -
News Biden backs Cold-War measures to shore-up medical supply chains
In a recent strategy to combat rising inflation and the cost of living crisis, President Joe Biden has invoked a Cold War-era act to increase investment in a selection of medicines and supplies. -
News Women in Pharma: Delivering solutions for gender diversity
In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
.png)
News CPHI Barcelona Speaker Interview – What the US FDA’s Quality Management Maturity Means for the Pharma Industry
At CPHI Barcelona (24–26 October, 2023), we spoke to Sireesha Yadlapalli, CEO of Pharmatech Associates, who gave a presentation on the implications of the US FDA’s Quality Management Maturity (QMM) Initiative, and spoke on the panel of the ... -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News Wegovy and weight-loss drugs driving demand for manufacturers that can fill syringes
Injectable weight-loss treatments are prompting contract manufacturers to invest and include fill-finish services into their service portfolios, in a bid to attract pharmaceutical giants developing drugs similar to Novo Nordisk's Wegovy.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance